Vancouver, British Columbia--(Newsfile Corp. - November 17, 2016) - Alliance Growers (CSE: ACG) is in the final stage of its
previously announced negotiations with WFS Pharmagreen, a private company located in Mission, British Columbia, and is close to
announcing terms of a planned $300,000 equity investment into Canna Companion Products, a wholly owned subsidiary of WFS
PharmaGreen.
InvestmentPitch.com has produced a "video
news alert" which discusses this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Alliance" in the search box. It is also available on
YouTube (click here).
Canna Companion, based in Washington State, operates a 5,000 square foot facility for the production and distribution of
cannabinoid infused pet products.
As part of the arrangement, Alliance will enter into a long-term contract to provide cannabinoid oil to Canna Companion
(www.cannacompanionusa.com) when it enters the Canadian market, which is expected in
2017.
Dennis Petke, President and CEO stated: "We are very proud of the achievements to date that Alliance Growers has accomplished
toward our goal of becoming a truly global cannabis company. We have multiple CBD oil supply contracts and potential investments
with growers under negotiation within North America and in other countries. In addition to Alliance Growers providing services and
plantlets to growers of all sizes, it is our vision to become the leading supplier of pharmaceutical grade CBD oil globally through
long term supply contracts. We look forward to unveiling our arrangements for participation in grow operations in
exchange for long term plantlet supply contracts and off take agreements for product that Alliance Growers will use for flower
and CBD oil sales. And in the coming months, Alliance Growers will unveil certain global arrangements currently under
negotiation."
Alliance previously announced that it had been granted a license from Botanical Research in Motion International, to jointly
develop and operate multiple Botany Centres in Canada. The terms of the license allow Alliance Growers to market and distribute all
present and future Tissue Culture plantlet products utilizing BRIM's proprietary "Chibafreen Invitro Plant Production System"
technology. This technology is critical to the mass production of disease-free, genetically identical, healthy starting plant
material.
Alliance and BRIM plan to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western
Canada to house a DNA Botany lab. To finance the development of the cannabis focused Botany Centre, the company has engaged DGWA,
the German Institute for Asset and Equity Allocation and Valuation, one of the leading German Corporate Boutiques providing
financial advisory services to global small and mid-cap companies. This venture will be assisted upon receipt of approval of its
pending Frankfurt Stock Exchange listing.
The company also announced a non-brokered private placement of up to 10 million units at a price of $0.20 per unit, for gross
proceeds of up to $2,000,000. Each unit is comprised of one common share and one warrant, with each warrant exercisable at $0.30
per share, for a period of two years.
The shares are currently trading at $0.30, and with 33 million shares outstanding, the company is capitalized at $9.9
million.
For more information, please visit the company's website, www.alliancegrowers.com,
contact Dennis Petke, President & CEO, at 778-331-4266 or email DennisPetke@AllianceGrowers.com.
About InvestmentPitch Media
InvestmentPitch Media is arguably the largest producer and distributer of video news content, primarily for small and mid-cap
companies. The company specializes in producing short videos based on significant news releases, research reports and other content
of interest to investors.
CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com
